NASDAQ: ROP
Roper Technologies
Technology · Industrial Instruments For Measurement, Display, and Control
52-week range
$305.96$470.01
Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.Figures shown are for the trailing 12 months to Jun 30, 2026. Hover or tap a column for another year.$33.5B
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $18.6B |
| FY2017, ended Dec 31, 2017 | $26.6B |
| FY2018, ended Dec 31, 2018 | $27.6B |
| FY2019, ended Dec 31, 2019 | $37.6B |
| FY2020, ended Dec 31, 2020 | $45.2B |
| FY2021, ended Dec 31, 2021 | $51.9B |
| FY2022, ended Dec 31, 2022 | $45.9B |
| FY2023, ended Dec 31, 2023 | $58.3B |
| FY2024, ended Dec 31, 2024 | $55.8B |
| FY2025, ended Dec 31, 2025 | $45.8B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $33.5B |
Revenue
By fiscal year, then the trailing 12 months.Figures shown are for the trailing 12 months to Jun 30, 2026. Hover or tap a column for another year.$8.28B
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $3.79B |
| FY2017, ended Dec 31, 2017 | $4.61B |
| FY2018, ended Dec 31, 2018 | $5.19B |
| FY2019, ended Dec 31, 2019 | $4.73B |
| FY2020, ended Dec 31, 2020 | $4.02B |
| FY2021, ended Dec 31, 2021 | $4.83B |
| FY2022, ended Dec 31, 2022 | $5.37B |
| FY2023, ended Dec 31, 2023 | $6.18B |
| FY2024, ended Dec 31, 2024 | $7.04B |
| FY2025, ended Dec 31, 2025 | $7.90B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $8.28B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.Figures shown are for the trailing 12 months to Jun 30, 2026. Hover or tap a column for another year.Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $659M | $927M |
| FY2017, ended Dec 31, 2017 | $972M | $1.19B |
| FY2018, ended Dec 31, 2018 | $944M | $1.38B |
| FY2019, ended Dec 31, 2019 | $1.77B | $1.42B |
| FY2020, ended Dec 31, 2020 | $950M | $1.50B |
| FY2021, ended Dec 31, 2021 | $1.15B | $1.98B |
| FY2022, ended Dec 31, 2022 | $4.54B | $695M |
| FY2023, ended Dec 31, 2023 | $1.38B | $1.97B |
| FY2024, ended Dec 31, 2024 | $1.55B | $2.33B |
| FY2025, ended Dec 31, 2025 | $1.54B | $2.49B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $2.50B | $2.62B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.Figures shown are for the trailing 12 months to Jun 30, 2026. Hover or tap a column for another year.$365M
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $757M |
| FY2017, ended Dec 31, 2017 | $671M |
| FY2018, ended Dec 31, 2018 | $364M |
| FY2019, ended Dec 31, 2019 | $710M |
| FY2020, ended Dec 31, 2020 | $308M |
| FY2021, ended Dec 31, 2021 | $352M |
| FY2022, ended Dec 31, 2022 | $793M |
| FY2023, ended Dec 31, 2023 | $214M |
| FY2024, ended Dec 31, 2024 | $188M |
| FY2025, ended Dec 31, 2025 | $297M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $365M |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.Figures shown are for the trailing 12 months to Jun 30, 2026. Hover or tap a column for another year.$11.3B
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $6.21B |
| FY2017, ended Dec 31, 2017 | $5.16B |
| FY2018, ended Dec 31, 2018 | $4.94B |
| FY2019, ended Dec 31, 2019 | $5.28B |
| FY2020, ended Dec 31, 2020 | $9.56B |
| FY2021, ended Dec 31, 2021 | $7.92B |
| FY2022, ended Dec 31, 2022 | $6.66B |
| FY2023, ended Dec 31, 2023 | $6.33B |
| FY2024, ended Dec 31, 2024 | $7.62B |
| FY2025, ended Dec 31, 2025 | $9.30B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $11.3B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 2.5% since 2016.Figures shown are for the trailing 12 months to Jun 30, 2026. Hover or tap a column for another year.98.9M
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 101M |
| FY2017, ended Dec 31, 2017 | 103M |
| FY2018, ended Dec 31, 2018 | 104M |
| FY2019, ended Dec 31, 2019 | 106M |
| FY2020, ended Dec 31, 2020 | 105M |
| FY2021, ended Dec 31, 2021 | 106M |
| FY2022, ended Dec 31, 2022 | 106M |
| FY2023, ended Dec 31, 2023 | 107M |
| FY2024, ended Dec 31, 2024 | 107M |
| FY2025, ended Dec 31, 2025 | 103M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 98.9M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.Figures shown are for the trailing 12 months to Jun 30, 2026. Hover or tap a column for another year.Net: $3.03B more bought back than issued
Show tableHide table
| Period | Bought back | Paid to employees | Used in acquisitions |
|---|---|---|---|
| FY2016, ended Dec 31, 2016 | — | $78.8M | — |
| FY2017, ended Dec 31, 2017 | — | $83.1M | — |
| FY2018, ended Dec 31, 2018 | — | $134M | — |
| FY2019, ended Dec 31, 2019 | — | $101M | — |
| FY2020, ended Dec 31, 2020 | — | $108M | — |
| FY2021, ended Dec 31, 2021 | — | $123M | — |
| FY2022, ended Dec 31, 2022 | — | $119M | — |
| FY2023, ended Dec 31, 2023 | $0 | $124M | — |
| FY2024, ended Dec 31, 2024 | $0 | $146M | — |
| FY2025, ended Dec 31, 2025 | $500M | $166M | $7.30M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $3.23B | $192M | — |
Revenue (TTM)
$8.28B
+10.9% YoY
Net income (TTM)
$2.50B
+62.7% YoY
Cash
$365M
+50.5% YoY
Total debt
$11.3B
+27.8% YoY
Valuation
At current price- Market Cap
- $46.1B
- P/E
- 18.4×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 5.6×
- Price / Book
- 2.5×
- EV / EBITDA
- 17.6×
Growth
Trailing 12 months- Revenue (TTM)
- $8.28B
- Revenue Growth YoY
- 10.9%
- Revenue CAGR 3Y
- 13.7%
- Revenue CAGR 5Y
- 14.5%
- EPS Growth YoY
- 68.5%
- Net Income Growth YoY
- 62.7%
Profitability
Trailing 12 months- Gross Margin
- 69.5%
- Operating Margin
- 28.0%
- Net Margin
- 30.2%
- FCF Margin
- 31.7%
- Return on Equity
- 13.1%
Earnings
Trailing 12 months- Net Income
- $2.50B
- EPS (diluted)
- $24.00
- EBITDA
- $3.24B
- Operating Income
- $2.32B
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $365M
- Total Debt
- $11.3B
- Net Debt
- $11.0B
- Total Assets
- $35.2B
- Total Liabilities
- $16.5B
- Shareholders' Equity
- $18.7B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $2.67B
- Capital Expenditure
- $46.7M
- Free Cash Flow
- $2.62B
Dividends and risk
Last 12 months- Dividend Yield
- 0.8%
- Dividend / Share
- $3.64
- Beta (5Y)
- 0.76
Every ratio is calculated from the company’s reported figures.
Strength
Revenue is up 10.9% year over year, at $8.28B.
Strength
Keeps 28.0% of revenue as operating profit.
Watch
Net debt is 3.4× EBITDA ($11.0B), a heavy load.
Strength
Turns 31.7% of revenue into free cash flow.
Written by fixed rules from the reported figures, not by a person or an AI.
Latest report
Pro10-K for the fiscal year ended Dec 31, 2025 · filed Feb 24, 2026
The score and findings for the newest report are part of CoreStock Pro, coming soon. Every earlier report is free.
Score of each annual report
0 to 100 · 60 means nothing notable · tap a column for its details
2024 · 10-K65Mildly positive
65Mildly positive
10-K for the fiscal year ended Dec 31, 2024
Filed Feb 24, 2025 · Read the filing on EDGAR
- Revenue rose 13.9% to $7.04 billion. Organic growth was 5.8%, and acquisitions, mainly Procare and Transact, added 8.1%.
- Net earnings from continuing operations rose about 13%, helped by a $135.6 million gain on selling the Certinia stake and a $96.4 million rise in Indicor's value.
- Debt rose to $7.67 billion after $2 billion of new notes, and interest expense jumped 57%. Operating cash flow grew 17% to $2.39 billion.
- Backlog in Technology Enabled Products fell 40% as customers stopped ordering far ahead for supply-chain reasons. Total backlog slipped 1.6%.
Business momentum
Improving
“Net revenues for the year ended December 31, 2024 were $7,039.2 as compared to $6,177.8 for the year ended December 31, 2023, an increase of 13.9%.”
Outlook
Neutral
“We anticipate that our businesses will generate positive cash flows from operating activities, and that these cash flows will permit the reduction of currently outstanding debt in accordance with the repayment schedule.”
Financial stress
Low
“We believe that internally generated cash flows and the remaining availability under our unsecured credit facility will be adequate to finance our normal operating requirements.”
Tone against the previous report
About the same
Red flags
None found in this report.
Positives
Organic growth in every segment
“The growth of 5.6% in organic revenues was broad-based across the segment led by our businesses serving the project-based business/government contracting, acute healthcare, property and casualty insurance, and legal markets.”
Strong rise in operating cash flow
“Net cash provided by operating activities from continuing operations increased by 17% to $2,393.2 in 2024 as compared to $2,037.4 in 2023”
Operating margins rose in all three segments
“The resulting operating margin was 45.2% in the year ended December 31, 2024 as compared to 43.9% in the year ended December 31, 2023.”
Concerns
Higher debt and interest costs
“Interest expense, net, increased by $94.5, or a 57.4% increase, to $259.2 for the year ended December 31, 2024 as compared to $164.7 for the year ended December 31, 2023.”
Sharp fall in hardware backlog
“Backlog decreased 1.6% to $3,105.4 at December 31, 2024 as compared to $3,156.6 at December 31, 2023 due primarily to a decrease in our Technology Enabled Products segment”
Weakness in freight and media businesses
“partially offset by a decline in our businesses serving the media and entertainment and freight match markets primarily related to end market conditions.”
New risks since the previous report
Tariffs and possible cuts in government spending
“Changes in political administrations in the U.S. and elsewhere may lead to variability in, or reallocation of, government spending priorities, or a reduction in government spend”
New AI rules such as the EU AI Act
“For example, the EU AI Act places new requirements on providers of AI technologies that will need to be addressed in alignment with various deadlines in the coming years.”
Biggest risks named
- $7.7 billion of debt and loan covenant limits
- Possible write-down of $19.3 billion of goodwill
- Dependence on buying and integrating companies
- Cybersecurity, cloud outages and data privacy rules
- Value of the Indicor stake Roper doesn't control
Artificial intelligence in this business: Mentioned
How the score adds up
| Starting point | 60 | |
| Business momentum | +6 | |
| Outlook | 0 | |
| Tone against the previous report | 0 | |
| Financial stress | 0 | |
| Red flags | 0 | |
| New risks | −1 | |
| Score | 65 | |
Written by AI (Claude Opus 5.5) from the report’s text. 11 of 11 quotes were found word for word in the filing; the rest are left out. Not investment advice.
All scored reports
| Period | Report | Filed | Score | Momentum | Red flags |
|---|---|---|---|---|---|
| 10-K | Feb 24, 2026 | Pro | |||
| 10-K | Feb 24, 2025 | 65 | Improving | None | |
| 10-K | Feb 22, 2024 | 71 | Strong improvement | None | |
| 10-K | Feb 27, 2023 | 69 | Strong improvement | 1 minor | |
| 10-K | Feb 22, 2022 | 71 | Strong improvement | 1 minor | |
| 10-K | Feb 22, 2021 | 50 | Mixed | 1 minor | |
| 10-K | Feb 28, 2020 | 65 | Improving | None | |
| 10-K | Feb 25, 2019 | 63 | Improving | 1 minor | |
| 10-K | Feb 23, 2018 | 73 | Strong improvement | None | |
| 10-K | Feb 27, 2017 | 52 | Improving | 1 minor |
How these scores work
An AI model reads the management discussion, risk factors and legal sections of each report and records what they say, quoting the filing word for word. Fixed rules then turn those findings into a score from 0 to 100, where 60 means nothing notable either way. A score describes the report, not whether the stock is a good investment, and the AI may know how things turned out later, which can colour older scores. Read the methodology
From the 10-Q for Q2 FY2026 (period ended Jun 30, 2026), filed Jul 31, 2026. View filings on SEC EDGAR